Docetaxel ± gefitinib in recurrent or metastatic head and neck cancer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Docetaxel ± gefitinib in recurrent or metastatic head and neck cancer'. Together they form a unique fingerprint.